Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma-aminobutyric acid type B receptor subunit 1 (GABBR1) is a protein that forms part of the GABA_B receptor, a G-protein coupled receptor (GPCR) for GABA, the main inhibitory neurotransmitter in the mammalian central nervous system. The functional GABA_B receptor operates as an obligate heterodimer with GABBR2. Variants or dysfunctions in this gene have been linked to several neurodevelopmental disorders including neurodevelopmental disorder with language delay and intellectual disability. Susceptibility loci for multiple sclerosis, epilepsy, schizophrenia—and possibly other neuropsychiatric conditions—have been mapped near or within this region on chromosome 6p21.3 where GABBR1 resides.
Activation of inwardly rectifying potassium channels, leading to hyperpolarization of neurons and inhibition of neurotransmitter release
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type B receptor subunit 1.